Robert H Paul1,2, Kyu Cho3, Andrew Belden3, Adam W Carrico4, Eileen Martin5, Jacob Bolzenius3, Patrick Luckett6, Sarah A Cooley6, Julie Mannarino3, Jodi M Gilman7, Mariah Miano8, Beau M Ances6. 1. Department of Psychological Sciences, University of Missouri Saint Louis, Missouri, Saint Louis, US. paulro@umsl.edu. 2. Missouri Institute of Mental Health, University of Missouri Saint Louis, Missouri, Saint Louis, US. paulro@umsl.edu. 3. Missouri Institute of Mental Health, University of Missouri Saint Louis, Missouri, Saint Louis, US. 4. Department of Public Health, University of Miami School of Medicine, Coral Gables, Florida, US. 5. Department of Psychiatry, Rush University School of Medicine, Chicago, Illinois, US. 6. Department of Neurology, Washington University, Saint Louis, Missouri, US. 7. Center for Addiction Medicine, Harvard Medical School/Massachusetts General Hospital, Boston, Massachusetts, US. 8. Department of Communication Sciences and Disorders, Northern Arizona University, Flagstaff, Arizona, US.
Abstract
The current study applied data-driven methods to identify and explain novel cognitive phenotypes of HIV. Methods: 388 people with HIV (PWH) with an average age of 46 (15.8) and median plasma CD4+ T-cell count of 555 copies/mL (79% virally suppressed) underwent cognitive testing and 3T neuroimaging. Demographics, HIV disease variables, and health comorbidities were recorded within three months of cognitive testing/neuroimaging. Hierarchical clustering was employed to identify cognitive phenotypes followed by ensemble machine learning to delineate the features that determined membership in the cognitive phenotypes. Hierarchical clustering identified five cognitive phenotypes. Cluster 1 (n=97) was comprised of individuals with normative performance on all cognitive tests. The remaining clusters were defined by impairment on action fluency (Cluster 2; n=46); verbal learning/memory (Cluster 3; n=73); action fluency and verbal learning/memory (Cluster 4; n=56); and action fluency, verbal learning/memory, and tests of executive function (Cluster 5; n=114). HIV detectability was most common in Cluster 5. Machine learning revealed that polysubstance use, race, educational attainment, and volumes of the precuneus, cingulate, nucleus accumbens, and thalamus differentiated membership in the normal vs. impaired clusters. The determinants of persistent cognitive impairment among PWH receiving suppressive treatment are multifactorial nature. Viral replication after ART plays a role in the causal pathway, but psychosocial factors (race inequities, substance use) merit increased attention as critical determinants of cognitive impairment in the context of ART. Results underscore the need for comprehensive person-centered interventions that go beyond adherence to patient care to achieve optimal cognitive health among PWH.
The current study applied data-driven methods to identify and explain novel cognitive phenotypes of HIV. Methods: 388 people with HIV (PWH) with an average age of 46 (15.8) and median plasma CD4+ T-cell count of 555 copies/mL (79% virally suppressed) underwent cognitive testing and 3T neuroimaging. Demographics, HIV disease variables, and health comorbidities were recorded within three months of cognitive testing/neuroimaging. Hierarchical clustering was employed to identify cognitive phenotypes followed by ensemble machine learning to delineate the features that determined membership in the cognitive phenotypes. Hierarchical clustering identified five cognitive phenotypes. Cluster 1 (n=97) was comprised of individuals with normative performance on all cognitive tests. The remaining clusters were defined by impairment on action fluency (Cluster 2; n=46); verbal learning/memory (Cluster 3; n=73); action fluency and verbal learning/memory (Cluster 4; n=56); and action fluency, verbal learning/memory, and tests of executive function (Cluster 5; n=114). HIV detectability was most common in Cluster 5. Machine learning revealed that polysubstance use, race, educational attainment, and volumes of the precuneus, cingulate, nucleus accumbens, and thalamus differentiated membership in the normal vs. impaired clusters. The determinants of persistent cognitive impairment among PWH receiving suppressive treatment are multifactorial nature. Viral replication after ART plays a role in the causal pathway, but psychosocial factors (race inequities, substance use) merit increased attention as critical determinants of cognitive impairment in the context of ART. Results underscore the need for comprehensive person-centered interventions that go beyond adherence to patient care to achieve optimal cognitive health among PWH.
Authors: Desiree A Byrd; S Walden Miller; Judy Reilly; Shirley Weber; Tamara L Wall; Robert K Heaton Journal: Clin Neuropsychol Date: 2006-06 Impact factor: 3.535
Authors: Pariya L Fazeli; Michael Crowe; Lesley A Ross; Virginia Wadley; Karlene Ball; David E Vance Journal: J Clin Res HIV AIDS Prev Date: 2014-02-18
Authors: Adam W Carrico; Peter W Hunt; Torsten B Neilands; Samantha E Dilworth; Jeffrey N Martin; Steven G Deeks; Elise D Riley Journal: J Acquir Immune Defic Syndr Date: 2019-01-01 Impact factor: 3.731
Authors: Chloe W Eng; Medellena Maria Glymour; Paola Gilsanz; Dan M Mungas; Elizabeth R Mayeda; Oanh L Meyer; Rachel A Whitmer Journal: Alzheimer Dis Assoc Disord Date: 2021 Apr-Jun 01 Impact factor: 2.703
Authors: Rebecca E Amariglio; Rachel F Buckley; Jennifer S Rabin; Kathryn V Papp; Yakeel T Quiroz; Elizabeth C Mormino; Kathryn P Sparks; Keith A Johnson; Dorene M Rentz; Reisa A Sperling Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Raha M Dastgheyb; Ned Sacktor; Donald Franklin; Scott Letendre; Thomas Marcotte; Robert Heaton; Igor Grant; Justin C McArthur; Leah H Rubin; Norman J Haughey Journal: J Acquir Immune Defic Syndr Date: 2019-09-01 Impact factor: 3.771